Mahomed K, Jayaguru A S
Harare Maternity Hospital, Department of Obstetrics, University of Zimbabwe Medical School, Zimbabwe.
Br J Obstet Gynaecol. 1997 Sep;104(9):1058-61. doi: 10.1111/j.1471-0528.1997.tb12067.x.
To compare the effectiveness of extra-amniotic saline with intra-amniotic prostaglandin F2 alpha in inducing labour in pregnancies with intrauterine fetal death.
A randomised controlled trial.
One hundred and twenty-one women in the extra-amniotic saline group and 123 women in the intra-amniotic prostaglandin group, performed at Harare Maternity Hospital, Zimbabwe during the period October 1994 to February 1996.
The two methods were equally effective in achieving delivery. The number of women not delivering within 48 hours of recruitment was 6% for the extra-amniotic saline group compared with 11% for the intra-amniotic prostaglandin group (relative risk [RR] 0.51, 95% CI 0.21-1.22). The extra-amniotic saline group required augmentation with Syntocinon more frequently than the intra-amniotic prostaglandin group: 22% compared with 7% (RR 3.1, 95% CI 1.5-6.2). There were more complications associated with the intra-amniotic prostaglandin group: five women developed hypertonic contractions compared with none in the extra-amniotic saline group. In addition 23% of women in the intra-amniotic prostaglandin group developed acute vasovagal-like symptoms lasting for about 10 to 15 minutes which were distressing for the women. There was no evidence of any increase in febrile morbidity from extra-amniotic saline (RR 0.8, 95% CI 0.75-1.1).
Extra-amniotic saline infusion in successful in inducing labour in antepartum fetal deaths after 20 weeks of gestation. This method has been shown to be safe and well tolerated by the women and should be considered in areas with limited resources. This method should be evaluated further for inductions of labour with a live fetus.
比较羊膜外注入生理盐水与羊膜腔内注入前列腺素F2α在引产宫内死胎中的有效性。
一项随机对照试验。
1994年10月至1996年2月期间,在津巴布韦哈拉雷妇产医院进行的研究,羊膜外注入生理盐水组121名妇女,羊膜腔内注入前列腺素组123名妇女。
两种方法在实现分娩方面同样有效。在招募后48小时内未分娩的妇女比例,羊膜外注入生理盐水组为6%,而羊膜腔内注入前列腺素组为11%(相对危险度[RR]0.51,95%可信区间0.21 - 1.22)。羊膜外注入生理盐水组比羊膜腔内注入前列腺素组更频繁地需要用缩宫素加强宫缩:分别为22%和7%(RR 3.1,95%可信区间1.5 - 6.2)。羊膜腔内注入前列腺素组有更多并发症:5名妇女出现高张性宫缩,而羊膜外注入生理盐水组无此情况。此外,羊膜腔内注入前列腺素组23%的妇女出现急性血管迷走样症状,持续约10至15分钟,给妇女带来痛苦。没有证据表明羊膜外注入生理盐水会增加发热性发病率(RR 0.8,95%可信区间0.75 - 1.1)。
羊膜外注入生理盐水在妊娠20周后引产产前死胎方面是成功的。该方法已被证明对妇女安全且耐受性良好,在资源有限的地区应予以考虑。该方法应进一步评估用于活胎引产的情况。